カテゴリー： Infiniti Research TechNavio, 世界, 医療/バイオ

世界の多発性嚢胞腎（PKD）治療薬市場2022年～2026年

【英語タイトル】Global Polycystic Kidney Disease Drugs Market 2022-2026

Technavioが出版した調査資料（IRTNTR70229-22）・商品コード：IRTNTR70229-22
・発行会社（調査会社）：Technavio
・発行日：2022年7月19日
・ページ数：約120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：北米、 ヨーロッパ、 アジア、 その他地域
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥365,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥584,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
Technavio社発行の最新調査レポートでは、世界の多発性嚢胞腎（PKD）治療薬市場規模が2022年から2026年まで年平均6.7％成長し、510.69百万ドルに達すると予測しています。当書では、多発性嚢胞腎（PKD）治療薬の世界市場を総合的に調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、種類別（ADPKD、ARPKD）分析、顧客状況、地域別状況（北米、ヨーロッパ、アジア、アメリカ、ドイツ、中国、イギリス、カナダ）、推進要因・課題・動向、企業状況、企業分析などの項目をまとめています。なお、当書に掲載されている企業情報には、Apotex Inc.、AstraZeneca Plc、Dr. Reddys Laboratories Ltd.、Galapagos NV、Johnson and Johnson、Merck and Co. Inc.、Novartis AG、Otsuka Holdings Co. Ltd.、Palladio Biosciences Inc.、Reata Pharmaceuticals Inc.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の多発性嚢胞腎（PKD）治療薬市場規模：種類別
- ADPKDの市場規模2021-2026
- ARPKDの市場規模2021-2026
・顧客状況
・地域別状況
- 北米の多発性嚢胞腎（PKD）治療薬市場規模2021-2026
- ヨーロッパの多発性嚢胞腎（PKD）治療薬市場規模2021-2026
- アジアの多発性嚢胞腎（PKD）治療薬市場規模2021-2026
- アメリカの多発性嚢胞腎（PKD）治療薬市場規模2021-2026
- ドイツの多発性嚢胞腎（PKD）治療薬市場規模2021-2026
- 中国の多発性嚢胞腎（PKD）治療薬市場規模2021-2026
- イギリスの多発性嚢胞腎（PKD）治療薬市場規模2021-2026
- カナダの多発性嚢胞腎（PKD）治療薬市場規模2021-2026
・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。 Technavio社の市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。
❖ レポートの概要 ❖

Global Polycystic Kidney Disease Drugs Market 2022-2026

Technavio has been monitoring the polycystic kidney disease drugs market and it is poised to grow by $ 510.69 mn during 2022-2026, accelerating at a CAGR of 6.7% during the forecast period. Our report on the polycystic kidney disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the high prevalence of chronic kidney diseases, special regulatory designations, and increasing R&D for developing new drugs.

The polycystic kidney disease drugs market analysis includes type segment and geographic landscape.
Technavio’s polycystic kidney disease drugs market is segmented as below:

By Type
• ADPKD
• ARPKD

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing research funding as one of the prime reasons driving the polycystic kidney disease drugs market growth during the next few years. Also, favorable reimbursement policies and growing awareness about kidney diseases will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the polycystic kidney disease drugs market covers the following areas:
• Polycystic kidney disease drugs market sizing
• Polycystic kidney disease drugs market forecast
• Polycystic kidney disease drugs market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading polycystic kidney disease drugs market vendors that include Apotex Inc., AstraZeneca Plc, Dr. Reddys Laboratories Ltd., Galapagos NV, Johnson and Johnson, Merck and Co. Inc., Novartis AG, Otsuka Holdings Co. Ltd., Palladio Biosciences Inc., Reata Pharmaceuticals Inc., Regulus Therapeutics Inc., Sanofi, Teva Pharmaceutical Industries Ltd., and XORTX Therapeutics Inc. Also, the polycystic kidney disease drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type – Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 ADPKD – Market size and forecast 2021-2026
o Exhibit 28: Chart on ADPKD – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on ADPKD – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on ADPKD – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on ADPKD – Year-over-year growth 2021-2026 (%)
o 5.4 ARPKD – Market size and forecast 2021-2026
o Exhibit 32: Chart on ARPKD – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on ARPKD – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on ARPKD – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on ARPKD – Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 42: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 58: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 Germany – Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.9 China – Market size and forecast 2021-2026
o Exhibit 66: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.10 UK – Market size and forecast 2021-2026
o Exhibit 70: Chart on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK – Year-over-year growth 2021-2026 (%)
o 7.11 Canada – Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 AstraZeneca Plc
o Exhibit 85: AstraZeneca Plc – Overview
o Exhibit 86: AstraZeneca Plc – Product / Service
o Exhibit 87: AstraZeneca Plc – Key news
o Exhibit 88: AstraZeneca Plc – Key offerings
o 10.4 Galapagos NV
o Exhibit 89: Galapagos NV – Overview
o Exhibit 90: Galapagos NV – Product / Service
o Exhibit 91: Galapagos NV – Key offerings
o 10.5 Johnson and Johnson
o Exhibit 92: Johnson and Johnson – Overview
o Exhibit 93: Johnson and Johnson – Business segments
o Exhibit 94: Johnson and Johnson – Key news
o Exhibit 95: Johnson and Johnson – Key offerings
o Exhibit 96: Johnson and Johnson – Segment focus
o 10.6 Merck and Co. Inc.
o Exhibit 97: Merck and Co. Inc. – Overview
o Exhibit 98: Merck and Co. Inc. – Business segments
o Exhibit 99: Merck and Co. Inc. – Key news
o Exhibit 100: Merck and Co. Inc. – Key offerings
o Exhibit 101: Merck and Co. Inc. – Segment focus
o 10.7 Otsuka Holdings Co. Ltd.
o Exhibit 102: Otsuka Holdings Co. Ltd. – Overview
o Exhibit 103: Otsuka Holdings Co. Ltd. – Business segments
o Exhibit 104: Otsuka Holdings Co. Ltd. – Key offerings
o Exhibit 105: Otsuka Holdings Co. Ltd. – Segment focus
o 10.8 Palladio Biosciences Inc.
o Exhibit 106: Palladio Biosciences Inc. – Overview
o Exhibit 107: Palladio Biosciences Inc. – Product / Service
o Exhibit 108: Palladio Biosciences Inc. – Key offerings
o 10.9 Reata Pharmaceuticals Inc.
o Exhibit 109: Reata Pharmaceuticals Inc. – Overview
o Exhibit 110: Reata Pharmaceuticals Inc. – Product / Service
o Exhibit 111: Reata Pharmaceuticals Inc. – Key offerings
o 10.10 Regulus Therapeutics Inc.
o Exhibit 112: Regulus Therapeutics Inc. – Overview
o Exhibit 113: Regulus Therapeutics Inc. – Product / Service
o Exhibit 114: Regulus Therapeutics Inc. – Key offerings
o 10.11 Sanofi
o Exhibit 115: Sanofi – Overview
o Exhibit 116: Sanofi – Business segments
o Exhibit 117: Sanofi – Key news
o Exhibit 118: Sanofi – Key offerings
o Exhibit 119: Sanofi – Segment focus
o 10.12 XORTX Therapeutics Inc.
o Exhibit 120: XORTX Therapeutics Inc. – Overview
o Exhibit 121: XORTX Therapeutics Inc. – Product / Service
o Exhibit 122: XORTX Therapeutics Inc. – Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 123: Inclusions checklist
o Exhibit 124: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 125: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 126: Research methodology
o Exhibit 127: Validation techniques employed for market sizing
o Exhibit 128: Information sources
o 11.5 List of abbreviations
o Exhibit 129: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Type – Market share 2021-2026 (%)
Exhibits25: Data Table on Type – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on ADPKD – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on ADPKD – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on ADPKD – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on ADPKD – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on ARPKD – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on ARPKD – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on ARPKD – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on ARPKD – Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AstraZeneca Plc – Overview
Exhibits86: AstraZeneca Plc – Product / Service
Exhibits87: AstraZeneca Plc – Key news
Exhibits88: AstraZeneca Plc – Key offerings
Exhibits89: Galapagos NV – Overview
Exhibits90: Galapagos NV – Product / Service
Exhibits91: Galapagos NV – Key offerings
Exhibits92: Johnson and Johnson – Overview
Exhibits93: Johnson and Johnson – Business segments
Exhibits94: Johnson and Johnson – Key news
Exhibits95: Johnson and Johnson – Key offerings
Exhibits96: Johnson and Johnson – Segment focus
Exhibits97: Merck and Co. Inc. – Overview
Exhibits98: Merck and Co. Inc. – Business segments
Exhibits99: Merck and Co. Inc. – Key news
Exhibits100: Merck and Co. Inc. – Key offerings
Exhibits101: Merck and Co. Inc. – Segment focus
Exhibits102: Otsuka Holdings Co. Ltd. – Overview
Exhibits103: Otsuka Holdings Co. Ltd. – Business segments
Exhibits104: Otsuka Holdings Co. Ltd. – Key offerings
Exhibits105: Otsuka Holdings Co. Ltd. – Segment focus
Exhibits106: Palladio Biosciences Inc. – Overview
Exhibits107: Palladio Biosciences Inc. – Product / Service
Exhibits108: Palladio Biosciences Inc. – Key offerings
Exhibits109: Reata Pharmaceuticals Inc. – Overview
Exhibits110: Reata Pharmaceuticals Inc. – Product / Service
Exhibits111: Reata Pharmaceuticals Inc. – Key offerings
Exhibits112: Regulus Therapeutics Inc. – Overview
Exhibits113: Regulus Therapeutics Inc. – Product / Service
Exhibits114: Regulus Therapeutics Inc. – Key offerings
Exhibits115: Sanofi – Overview
Exhibits116: Sanofi – Business segments
Exhibits117: Sanofi – Key news
Exhibits118: Sanofi – Key offerings
Exhibits119: Sanofi – Segment focus
Exhibits120: XORTX Therapeutics Inc. – Overview
Exhibits121: XORTX Therapeutics Inc. – Product / Service
Exhibits122: XORTX Therapeutics Inc. – Key offerings
Exhibits123: Inclusions checklist
Exhibits124: Exclusions checklist
Exhibits125: Currency conversion rates for US$
Exhibits126: Research methodology
Exhibits127: Validation techniques employed for market sizing
Exhibits128: Information sources
Exhibits129: List of abbreviations



★調査レポート[世界の多発性嚢胞腎（PKD）治療薬市場2022年～2026年] (コード：IRTNTR70229-22)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の多発性嚢胞腎（PKD）治療薬市場2022年～2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の性感染症（STD）治療薬市場2022年～2026年
    IRTNTR74264-22 / Technavio / 2022年9月2日 / Technavio社の調査レポートによると、世界の性感染症（STD）治療薬市場規模は2022年から2026年まで年平均4.27％成長し、134.8億ドルに達する見込みです。本書では、性感染症（STD）治療薬の世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、種類別（ウイルス感染、バクテリア感染、その他）分析、顧客状況、地域別状況（北米、ヨーロッパ、アジア、アメリカ、日本、中国、ドイツ、イギリス）分析、推進要因・課題・動向、企業状況、企業分析など、多面的に分析を行っています。本書には、主要プレイヤーとしてAbbVie Inc.、Affymetrix、Aurobindo...
  • 世界の心筋梗塞（MI）治療薬市場2022年-2026年
    IRTNTR72581-22 / Technavio / 2022年2月23日 / テクナビオ社は、世界の心筋梗塞（MI）治療薬市場規模が2022年から2026年まで年平均4.72％成長し、20.2億ドルに達すると予測しています。本調査レポートは、心筋梗塞（MI）治療薬の世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別（抗血栓薬、血管拡張薬、血栓溶解薬、その他）分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析など、以下の項目をまとめております。 ・エグゼクティブサマリー...
  • 世界の勃起不全（ED）治療薬市場2022年-2026年
    IRTNTR72378-22 / Technavio / 2022年3月7日 / テクナビオ社は、世界の勃起不全（ED）治療薬市場規模が2022年から2026年まで年平均6.1％成長し、12.0億ドルに達すると予測しています。本調査レポートは、勃起不全（ED）治療薬の世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別（経口用、局所用、その他）分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析など、以下の項目をまとめております。 ・エグゼクティブサマリー...
  • 世界のヒトパピローマウイルス（HPV）治療薬市場2022年-2026年
    IRTNTR72565-22 / Technavio / 2022年3月10日 / テクナビオ社は、世界のヒトパピローマウイルス（HPV）治療薬市場規模が2022年から2026年まで年平均5.15％成長し、812百万ドルに達すると予測しています。本調査レポートは、ヒトパピローマウイルス（HPV）治療薬の世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、投与経路別（非経口、局所）分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析など、以下の項目をまとめております。 ・エグゼクティブサマリー...
  • 世界のナルコレプシー（居眠り病）治療薬市場2022年～2026年
    IRTNTR73929-22 / Technavio / 2022年7月22日 / Technavio社の最新調査レポートによると、世界のナルコレプシー（居眠り病）治療薬市場規模は2022年から2026年までの間に年平均9.1％成長し、16.0億ドルに達する見通しです。当書では、ナルコレプシー（居眠り病）治療薬の世界市場を広く調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、種類別（脱力発作併発型ナルコレプシー、非脱力発作併発型ナルコレプシー、二次ナルコレプシー）分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析などの内容をまとめております。なお、本書に掲載されている企業情報には、Alkermes Public...

    • ◆H&Iグローバルリサーチのお客様（例）◆